satavaptan has been researched along with Acute Kidney Failure in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jepsen, P; Vilstrup, H; Watson, H; Wong, F | 1 |
Bernard, A; Bonventre, JV; Chagnon, F; Guindi, C; Lesur, O; Plante, GE; Vaidya, VS | 1 |
1 trial(s) available for satavaptan and Acute Kidney Failure
Article | Year |
---|---|
Un-precipitated acute kidney injury is uncommon among stable patients with cirrhosis and ascites.
Topics: Acute Kidney Injury; Aged; Ascites; Creatinine; Diuretics; Female; Humans; Internationality; Liver Cirrhosis; Male; Middle Aged; Morpholines; Paracentesis; Prognosis; Proportional Hazards Models; Severity of Illness Index; Spiro Compounds | 2018 |
1 other study(ies) available for satavaptan and Acute Kidney Failure
Article | Year |
---|---|
Modulation of aquaporin-2/vasopressin2 receptor kidney expression and tubular injury after endotoxin (lipopolysaccharide) challenge.
Topics: Acute Kidney Injury; Animals; Antidiuretic Hormone Receptor Antagonists; Aquaporin 2; Arginine Vasopressin; Creatinine; Endotoxins; Epinephrine; Glomerular Filtration Rate; Injections, Intraperitoneal; Kidney; Lipopolysaccharides; Male; Morpholines; Proteinuria; Random Allocation; Rats; Rats, Wistar; Receptors, Vasopressin; Renal Circulation; RNA, Messenger; Sepsis; Spiro Compounds; Uteroglobin; Vasoconstrictor Agents | 2008 |